双鹭药业
(002038)
| 流通市值：42.87亿 | | | 总市值：51.68亿 |
| 流通股本：8.52亿 | | | 总股本：10.27亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 464,364,532.53 | 762,592,919.17 | 644,080,637.12 | 519,399,513.15 |
| 交易性金融资产 | 627,103,048.94 | 473,016,131.79 | 512,011,845.82 | 498,947,645.02 |
| 应收票据及应收账款 | 77,768,809.5 | 76,020,680.05 | 83,131,468.65 | 80,548,555.11 |
| 应收账款 | 77,768,809.5 | 76,020,680.05 | 83,131,468.65 | 80,548,555.11 |
| 应收款项融资 | - | 39,200 | 12,439.8 | 381,807.8 |
| 预付款项 | 98,012,210.73 | 103,016,326.12 | 133,637,601.12 | 164,728,343.58 |
| 其他应收款合计 | 8,637,102.47 | 8,846,760.77 | 12,087,355.31 | 14,070,714.58 |
| 存货 | 122,680,918.89 | 141,553,294.83 | 555,144,308.32 | 681,813,145.03 |
| 一年内到期的非流动资产 | - | - | - | 21,792,000 |
| 其他流动资产 | 5,390,767.51 | 5,987,722.84 | 108,772,188.14 | 112,280,530.88 |
| 流动资产合计 | 1,403,957,390.57 | 1,571,073,035.57 | 2,048,877,844.28 | 2,093,962,255.15 |
| 非流动资产: | | | | |
| 长期股权投资 | 892,012,860.23 | 888,630,418.02 | 894,403,792.53 | 907,477,185.85 |
| 其他非流动金融资产 | 218,761,793.31 | 378,651,531.58 | 511,241,535.12 | 665,259,620.02 |
| 投资性房地产 | 11,591,383.89 | 11,817,815.64 | 12,044,247.39 | 12,270,679.14 |
| 固定资产 | 400,926,410.78 | 385,600,632.89 | 396,743,901.88 | 406,516,367.92 |
| 在建工程 | 120,477,415.53 | 138,948,766.86 | 136,580,677.81 | 135,018,335.85 |
| 无形资产 | 596,106,307.31 | 594,921,028.36 | 613,957,316.3 | 633,009,695.81 |
| 开发支出 | 505,158,351.85 | 513,718,922.96 | 509,972,507.42 | 502,443,595.61 |
| 长期待摊费用 | 1,300,290.66 | 1,300,290.66 | 1,439,760.74 | 1,439,760.74 |
| 递延所得税资产 | 49,851,067.73 | 50,238,891.81 | 49,688,120.47 | 53,700,447.49 |
| 其他非流动资产 | 945,306,995.99 | 739,568,479.36 | 661,828,655.94 | 660,980,622.49 |
| 非流动资产合计 | 3,741,492,877.28 | 3,703,396,778.14 | 3,787,900,515.6 | 3,978,116,310.92 |
| 资产总计 | 5,145,450,267.85 | 5,274,469,813.71 | 5,836,778,359.88 | 6,072,078,566.07 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 62,123,553.75 | 55,776,543.26 | 56,883,133.7 | 95,541,387.22 |
| 其中：应付票据 | 21,425,078.26 | 16,997,012 | 17,888,911.72 | 26,012,065.45 |
| 应付账款 | 40,698,475.49 | 38,779,531.26 | 38,994,221.98 | 69,529,321.77 |
| 预收款项 | 152,471.5 | - | 1,224,700 | 11,219.5 |
| 合同负债 | 12,107,512.06 | 16,843,450.06 | 385,121,067.64 | 491,956,698.99 |
| 应付职工薪酬 | 38,434,549 | 38,221,407.8 | 40,680,753.94 | 46,475,312.47 |
| 应交税费 | 4,468,904.65 | 4,001,446.75 | 2,555,419.87 | 2,440,499.61 |
| 其他应付款合计 | 81,155,624.38 | 85,914,391.54 | 84,446,834.33 | 50,267,221.63 |
| 应付股利 | - | 47,992.5 | - | 2,651,681.14 |
| 其他流动负债 | 868,964.43 | 1,155,109.09 | 34,450,817.91 | 42,894,895.96 |
| 流动负债合计 | 199,311,579.77 | 201,912,348.5 | 605,362,727.39 | 729,587,235.38 |
| 非流动负债: | | | | |
| 递延收益 | 73,796,803.92 | 73,796,803.92 | 38,796,803.92 | 41,071,202.35 |
| 递延所得税负债 | 45,276,944.35 | 65,982,655.51 | 91,301,878.95 | 112,834,888.98 |
| 非流动负债合计 | 119,073,748.27 | 139,779,459.43 | 130,098,682.87 | 153,906,091.33 |
| 负债合计 | 318,385,328.04 | 341,691,807.93 | 735,461,410.26 | 883,493,326.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,027,350,000 | 1,027,350,000 | 1,027,350,000 | 1,027,350,000 |
| 资本公积 | 61,549,655.86 | 61,549,655.86 | 61,549,655.86 | 61,549,655.86 |
| 其他综合收益 | -21,766,681.74 | -21,766,681.74 | -21,766,681.74 | -21,766,681.74 |
| 盈余公积 | 632,410,430.74 | 632,410,430.74 | 632,410,430.74 | 632,410,430.74 |
| 未分配利润 | 3,121,449,125.43 | 3,226,776,981.47 | 3,395,737,786.78 | 3,481,852,226.54 |
| 归属于母公司股东权益合计 | 4,820,992,530.29 | 4,926,320,386.33 | 5,095,281,191.64 | 5,181,395,631.4 |
| 少数股东权益 | 6,072,409.52 | 6,457,619.45 | 6,035,757.98 | 7,189,607.96 |
| 股东权益合计 | 4,827,064,939.81 | 4,932,778,005.78 | 5,101,316,949.62 | 5,188,585,239.36 |
| 负债和股东权益合计 | 5,145,450,267.85 | 5,274,469,813.71 | 5,836,778,359.88 | 6,072,078,566.07 |
| 公告日期 | 2026-10-29 | 2026-08-26 | 2026-04-29 | 2026-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |